AKEBIA THERAPEUTICS, INC. Restructuring Reserve, Settled without Cash
AKEBIA THERAPEUTICS, INC. (AKBA) reported Restructuring Reserve, Settled without Cash of $3.20 million for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-08-28.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2023-08-28
- AKEBIA THERAPEUTICS, INC. restructuring reserve, settled without cash for the quarter ending 2022-12-31 was -$56.00K.
- AKEBIA THERAPEUTICS, INC. restructuring reserve, settled without cash for the quarter ending 2022-09-30 was -$50.00K.
- AKEBIA THERAPEUTICS, INC. restructuring reserve, settled without cash for fiscal 2022 was $3.20M.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 6 month | Restructuring Reserve, Settled without Cash 9 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$56.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$106.00K derived: sum of 2 quarters · filed 2023-08-28 | $3.20M 10-K/A · filed 2023-08-28 | |
| 2022-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.25M 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $3.30M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |